NCT06427044View on ClinicalTrials.gov

Effect of Bupivacaine Liposome Anterior Serratus Deep Block on Chronic Pain After Breast Cancer Surgery: a Randomized Controlled Study

NANot yet recruitingINTERVENTIONAL

Enrollment

143

Participants

Timeline

Start Date

May 25, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Breast Cancer Patients With Chronic Pain After Surgery

Interventions

DRUG

Anterior serratus block group

Bupivacaine lipid 20mL (20mL 266mg bupivacaine liposomes) was ultrasound-guided for a single anterior serranus plane block

Trial Locations (1)

430000

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Lu Hua

OTHER

NCT06427044 - Effect of Bupivacaine Liposome Anterior Serratus Deep Block on Chronic Pain After Breast Cancer Surgery: a Randomized Controlled Study | Biotech Hunter | Biotech Hunter